Chapman, SR and Naughton, BD (2016) EU Falsified Medicines Directive mandatory requirements for secondary care: A concise review. Journal of Generic Medicines, 12 (3-4). pp. 95-101. ISSN 1741-7090

Full text not available from this repository.


Since the publication of the Falsified Medicines Directive in 2011 and the subsequent delegated regulation in February 2016, there has been much discussion surrounding the level of Falsified Medicines Directive compliance required by secondary care institutions. Due to the heterogeneous nature of the secondary care drug distribution cycle, the Falsified Medicines Directive allows certain dispensations for ‘healthcare institutions’, this manuscript reviews the Falsified Medicines Directive and delegated regulation in an effort to understand and explain these dispensations and the true impact of the Falsified Medicines Directive on secondary care in an effort to address common misconceptions amongst stakeholders.

Item Type: Article
Additional Information: This is the accepted author manuscript (AAM). The final published version (version of record) is available online via Sage at Please refer to any applicable terms of use of the publisher.
Uncontrolled Keywords: authentication, falsified medicines, directive, secondary care requirements
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine and Health Sciences > Institute for Science and Technology in Medicine
Depositing User: Symplectic
Date Deposited: 04 Aug 2016 08:26
Last Modified: 03 Sep 2018 08:44

Actions (login required)

View Item
View Item